EPSRC launches two new hubs to transform early disease diagnosis in the UK
Quantum-based technologies will explore infectious diseases, cancer and dementia
Read More
Tag: University of Birmingham
Trial investigates faecal microbiota transplantation to treat rare liver disease
Primary sclerosing cholangitis is estimated to affect one in 100,000 people worldwide annually
Read More
New study shows wearable trackers provide clinical use for heart disease patients
Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK
Read More
Study finds Parkinson’s disease SLT more effective than one used in NHS
The progressive neurodegenerative condition affects around 153,000 people in the UK
Read More
UK Researchers developing new tetanus test to identify global immunity gaps
The serious, rare condition is responsible for up to 7% of all neonatal deaths globally
Read More
Female cancer survivors at low risk of developing obstetric complications
According to WHO, around 15% of pregnant women will develop an obstetric complication
Read More
Ten-minute brain scan could improve diagnosis for paediatric brain cancer
Medulloblastoma is responsible for around 52 new cases in children in the UK every year
Read More
Birmingham’s VR-assisted training centre for excellence to support future vaccine makers
The centre will deliver free training, outreach materials and programmes
Read More
BBSRC to invest £12m into 62 UK bioscience research projects
The projects will explore early-stage ideas at the frontiers of bioscience
Read More
Nonacus partners with Birmingham University to develop bladder cancer test
Nonacus is aiming to launch the ‘highly sensitive’ non-invasive bladder cancer test within 12 months
Read More
Researchers identify molecular ‘cookie cutter’ technique for COVID-19 drug discovery
Researchers are aiming to isolate a stable form of the COVID-19 encounter complex
Read More
University of Birmingham researchers develop rapid COVID-19 RNA test
Test can give accurate results in under five minutes, according to researchers
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
